Literature DB >> 20595671

Soluble guanylate cyclase alpha1beta1 limits stroke size and attenuates neurological injury.

Dmitriy N Atochin1, Izumi Yuzawa, Qian Li, Kristen M Rauwerdink, Rajeev Malhotra, Junlei Chang, Peter Brouckaert, Cenk Ayata, Michael A Moskowitz, Kenneth D Bloch, Paul L Huang, Emmanuel S Buys.   

Abstract

BACKGROUND AND
PURPOSE: Nitric oxide mediates endothelium-dependent vasodilation, modulates cerebral blood flow, and determines stroke outcome. Nitric oxide signals in part by stimulating soluble guanylate cyclase (sGC) to synthesize cGMP. To study the role of sGC in stroke injury, we compared the outcome of cerebral ischemia and reperfusion in mice deficient in the alpha(1) subunit of sGC (sGCalpha(1)(-/-)) with that in wild-type mice.
METHODS: Blood pressure, cerebrovascular anatomy, and vasoreactivity of pressurized carotid arteries were compared in both mouse genotypes. Cerebral blood flow was measured before and during middle cerebral artery occlusion and reperfusion. We then assessed neurological deficit and infarct volume after 1 hour of occlusion and 23 hours of reperfusion and after 24 hours of occlusion.
RESULTS: Blood pressure and cerebrovascular anatomy were similar between genotypes. We found that vasodilation of carotid arteries in response to acetylcholine or sodium nitroprusside was diminished in sGCalpha(1)(-/-) compared with wild-type mice. Cerebral blood flow deficits did not differ between the genotypes during occlusion, but during reperfusion, cerebral blood flow was 45% less in sGCalpha(1)(-/-) mice. Infarct volumes and neurological deficits were similar after 24 hours of occlusion in both genotypes. After 1 hour of ischemia and 23 hours of reperfusion, infarct volumes were 2-fold larger and neurological deficits were worse in sGCalpha(1)(-/-) than in the wild-type mice.
CONCLUSIONS: sGCalpha(1) deficiency impairs vascular reactivity to nitric oxide and is associated with incomplete reperfusion, larger infarct size, and worse neurological damage, suggesting that cGMP generated by sGCalpha(1)beta(1) is protective in ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595671      PMCID: PMC3047459          DOI: 10.1161/STROKEAHA.109.577635

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  20 in total

1.  Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.

Authors:  Pieter Vermeersch; Emmanuel Buys; Peter Pokreisz; Glenn Marsboom; Fumito Ichinose; Patrick Sips; Marijke Pellens; Hilde Gillijns; Marc Swinnen; Amanda Graveline; Desire Collen; Mieke Dewerchin; Peter Brouckaert; Kenneth D Bloch; Stefan Janssens
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

2.  Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice.

Authors:  Emmanuel S Buys; Patrick Sips; Pieter Vermeersch; Michael J Raher; Elke Rogge; Fumito Ichinose; Mieke Dewerchin; Kenneth D Bloch; Stefan Janssens; Peter Brouckaert
Journal:  Cardiovasc Res       Date:  2008-03-13       Impact factor: 10.787

Review 3.  cGMP and cGMP-dependent protein kinase in platelets and blood cells.

Authors:  Ulrich Walter; Stepan Gambaryan
Journal:  Handb Exp Pharmacol       Date:  2009

4.  More than a retrograde messenger: nitric oxide needs two cGMP pathways to induce hippocampal long-term potentiation.

Authors:  Feras Taqatqeh; Evanthia Mergia; Angela Neitz; Ulf T Eysel; Doris Koesling; Thomas Mittmann
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

5.  Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system.

Authors:  Evanthia Mergia; Andreas Friebe; Oliver Dangel; Michael Russwurm; Doris Koesling
Journal:  J Clin Invest       Date:  2006-05-04       Impact factor: 14.808

Review 6.  Saving the ischemic penumbra: potential role for statins and phosphodiesterase inhibitors.

Authors:  Fabrizio Sallustio; Marina Diomedi; Diego Centonze; Paolo Stanzione
Journal:  Curr Vasc Pharmacol       Date:  2007-10       Impact factor: 2.719

7.  The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo.

Authors:  Dmitriy N Atochin; Annie Wang; Victor W T Liu; Jeffrey D Critchlow; Ana Paula V Dantas; Robin Looft-Wilson; Takahisa Murata; Salvatore Salomone; Hwa Kyoung Shin; Cenk Ayata; Michael A Moskowitz; Thomas Michel; William C Sessa; Paul L Huang
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

8.  sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models.

Authors:  Emmanuel S Buys; Anje Cauwels; Michael J Raher; Jonathan J Passeri; Ion Hobai; Sharon M Cawley; Kristen M Rauwerdink; Helene Thibault; Patrick Y Sips; Robrecht Thoonen; Marielle Scherrer-Crosbie; Fumito Ichinose; Peter Brouckaert; Kenneth D Bloch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-05       Impact factor: 4.733

9.  Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.

Authors:  Sofie Nimmegeers; Patrick Sips; Emmanuel Buys; Peter Brouckaert; Johan Van de Voorde
Journal:  Cardiovasc Res       Date:  2007-06-12       Impact factor: 10.787

Review 10.  A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow.

Authors:  Mark Willmot; Laura Gray; Claire Gibson; Sean Murphy; Philip M W Bath
Journal:  Nitric Oxide       Date:  2005-05       Impact factor: 4.427

View more
  15 in total

1.  cGMP-dependent protein kinase I in vascular smooth muscle cells improves ischemic stroke outcome in mice.

Authors:  Maria Shvedova; Maxim M Litvak; Jesse D Roberts; Dai Fukumura; Tomoaki Suzuki; İkbal Şencan; Ge Li; Paula Reventun; Emmanuel S Buys; Hyung-Hwan Kim; Sava Sakadžić; Cenk Ayata; Paul L Huang; Robert Feil; Dmitriy N Atochin
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-18       Impact factor: 6.200

2.  Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.

Authors:  Dominique Hervé; Anne Philippi; Reda Belbouab; Michel Zerah; Stéphane Chabrier; Sophie Collardeau-Frachon; Francoise Bergametti; Aurore Essongue; Eliane Berrou; Valérie Krivosic; Christian Sainte-Rose; Emmanuel Houdart; Frédéric Adam; Kareen Billiemaz; Marilyne Lebret; Sabine Roman; Sandrine Passemard; Gwenola Boulday; Audrey Delaforge; Stéphanie Guey; Xavier Dray; Hugues Chabriat; Peter Brouckaert; Maryjke Bryckaert; Elisabeth Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2014-02-27       Impact factor: 11.025

Review 3.  New insights into the role of soluble guanylate cyclase in blood pressure regulation.

Authors:  Emmanuel Buys; Patrick Sips
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-03       Impact factor: 2.894

4.  Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling.

Authors:  Robrecht Thoonen; Patrick Y Sips; Kenneth D Bloch; Emmanuel S Buys
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

5.  Soluble guanylate cyclase-α1 is required for the cardioprotective effects of inhaled nitric oxide.

Authors:  Yasuko Nagasaka; Emmanuel S Buys; Ester Spagnolli; Andrea U Steinbicker; Sarah R Hayton; Kristen M Rauwerdink; Peter Brouckaert; Warren M Zapol; Kenneth D Bloch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-21       Impact factor: 4.733

6.  Quantitative assessment of demyelination in ischemic stroke in vivo using macromolecular proton fraction mapping.

Authors:  Marina Y Khodanovich; Alena A Kisel; Andrey E Akulov; Dmitriy N Atochin; Marina S Kudabaeva; Valentina Y Glazacheva; Michael V Svetlik; Yana A Medvednikova; Lilia R Mustafina; Vasily L Yarnykh
Journal:  J Cereb Blood Flow Metab       Date:  2018-01-26       Impact factor: 6.200

Review 7.  Nitric oxide: considerations for the treatment of ischemic stroke.

Authors:  Nicole A Terpolilli; Michael A Moskowitz; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-15       Impact factor: 6.200

8.  Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice.

Authors:  Emmanuel S Buys; Michael J Raher; Andrew Kirby; Mohd Shahid; Shahid Mohd; David M Baron; Sarah R Hayton; Laurel T Tainsh; Patrick Y Sips; Kristen M Rauwerdink; Qingshang Yan; Robert E T Tainsh; Hannah R Shakartzi; Christine Stevens; Kelly Decaluwé; Maria da Gloria Rodrigues-Machado; Rajeev Malhotra; Johan Van de Voorde; Tong Wang; Peter Brouckaert; Mark J Daly; Kenneth D Bloch
Journal:  J Clin Invest       Date:  2012-05-08       Impact factor: 14.808

Review 9.  Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke.

Authors:  Philip Mw Bath; Kailash Krishnan; Jason P Appleton
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

10.  Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma.

Authors:  Emmanuel S Buys; Yu-Chieh Ko; Clemens Alt; Sarah R Hayton; Alexander Jones; Laurel T Tainsh; Ruiyi Ren; Andrea Giani; Maeva Clerté; Emma Abernathy; Robert E T Tainsh; Dong-Jin Oh; Rajeev Malhotra; Pankaj Arora; Nadine de Waard; Binglan Yu; Raphael Turcotte; Daniel Nathan; Marielle Scherrer-Crosbie; Stephanie J Loomis; Jae H Kang; Charles P Lin; Haiyan Gong; Douglas J Rhee; Peter Brouckaert; Janey L Wiggs; Meredith S Gregory; Louis R Pasquale; Kenneth D Bloch; Bruce R Ksander
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.